These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38438670)

  • 1. Correction: Bismuth-Based Therapy: The New Therapy for Obese Patients Undergoing Gastric Bypass Surgery?
    Cerqueira RM; Correia MR; Pita I; Vilar H; Sousa M; Veloso R; Manso MC
    Obes Surg; 2024 Apr; 34(4):1391. PubMed ID: 38438670
    [No Abstract]   [Full Text] [Related]  

  • 2. Bismuth-Based Therapy: The New Therapy for Obese Patients Undergoing Gastric Bypass Surgery?
    Maria CR; Rodriguez CM; Ines P; Helder V; Mafalda S; Ricardo V; Conceição MM
    Obes Surg; 2024 Jan; 34(1):123-127. PubMed ID: 37914885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term outcomes for super-super obese (BMI > or =60 kg/m2) patients undergoing weight loss surgery at a high-volume bariatric surgery center: laparoscopic adjustable gastric banding, laparoscopic gastric bypass, and open tubular gastric bypass.
    Stephens DJ; Saunders JK; Belsley S; Trivedi A; Ewing DR; Iannace V; Capella RF; Wasielewski A; Moran S; Schmidt HJ; Ballantyne GH
    Surg Obes Relat Dis; 2008; 4(3):408-15. PubMed ID: 18243060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Patient Age at Gastric Bypass Surgery With Long-term All-Cause and Cause-Specific Mortality.
    Davidson LE; Adams TD; Kim J; Jones JL; Hashibe M; Taylor D; Mehta T; McKinlay R; Simper SC; Smith SC; Hunt SC
    JAMA Surg; 2016 Jul; 151(7):631-7. PubMed ID: 26864395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helicobacter pylori eradication therapy in obese patients undergoing gastric bypass surgery--fourteen days superior to seven days?
    Cerqueira RM; Manso MC; Correia MR; Fernandes CD; Vilar H; Nora M; Martins P
    Obes Surg; 2011 Sep; 21(9):1377-81. PubMed ID: 20838918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bariatric surgery for severely obese adolescents.
    Sugerman HJ; Sugerman EL; DeMaria EJ; Kellum JM; Kennedy C; Mowery Y; Wolfe LG
    J Gastrointest Surg; 2003 Jan; 7(1):102-108. PubMed ID: 12559191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of opioid-containing anesthesia versus opioid-free anesthesia using the Cortínez-Sepúlveda model on differential cytokine responses in obese patients undergoing gastric bypass surgery: a randomized controlled trial.
    Campos-Pérez W; Ramírez-Plascencia L; Pérez-Robles M; Rivera-Valdés JJ; Sánchez-Muñoz P; Pérez-Vargas L; González-Landeros D; Cuevas JHM; Martínez-López E
    BMC Anesthesiol; 2022 Sep; 22(1):294. PubMed ID: 36114460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of objective outcomes following laparoscopic Nissen fundoplication versus laparoscopic gastric bypass in the morbidly obese with heartburn.
    Patterson EJ; Davis DG; Khajanchee Y; Swanström LL
    Surg Endosc; 2003 Oct; 17(10):1561-5. PubMed ID: 12874685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic characterization of nondiabetic severely obese patients undergoing Roux-en-Y gastric bypass: preoperative classification predicts the effects of gastric bypass on insulin-glucose homeostasis.
    Perugini RA; Quarfordt SH; Baker S; Czerniach DR; Litwin DE; Kelly JJ
    J Gastrointest Surg; 2007 Sep; 11(9):1083-90. PubMed ID: 17588192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of stone disease in morbidly obese patients undergoing gastric bypass surgery.
    Durrani O; Morrisroe S; Jackman S; Averch T
    J Endourol; 2006 Oct; 20(10):749-52. PubMed ID: 17094749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two-year changes in health-related quality of life in gastric bypass patients compared with severely obese controls.
    Kolotkin RL; Crosby RD; Gress RE; Hunt SC; Adams TD
    Surg Obes Relat Dis; 2009; 5(2):250-6. PubMed ID: 19306822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal cost experience for gastric bypass patients.
    Mullen DM; Marr TJ
    Surg Obes Relat Dis; 2010; 6(3):243-8. PubMed ID: 20510287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastric Bypass Surgery Leads to Long-term Remission or Improvement of Type 2 Diabetes and Significant Decrease of Microvascular and Macrovascular Complications.
    Chen Y; Corsino L; Shantavasinkul PC; Grant J; Portenier D; Ding L; Torquati A
    Ann Surg; 2016 Jun; 263(6):1138-42. PubMed ID: 26599565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probiotic Supplementation in Morbid Obese Patients Undergoing One Anastomosis Gastric Bypass-Mini Gastric Bypass (OAGB-MGB) Surgery: a Randomized, Double-Blind, Placebo-Controlled, Clinical Trial.
    Karbaschian Z; Mokhtari Z; Pazouki A; Kabir A; Hedayati M; Moghadam SS; Mirmiran P; Hekmatdoost A
    Obes Surg; 2018 Sep; 28(9):2874-2885. PubMed ID: 29725975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hedonic hunger is increased in severely obese patients and is reduced after gastric bypass surgery.
    Schultes B; Ernst B; Wilms B; Thurnheer M; Hallschmid M
    Am J Clin Nutr; 2010 Aug; 92(2):277-83. PubMed ID: 20519559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laparoscopic gastric bypass: risks vs. benefits up to two years following surgery in super-super obese patients.
    Gould JC; Garren MJ; Boll V; Starling JR
    Surgery; 2006 Oct; 140(4):524-9; discussion 529-31. PubMed ID: 17011899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enoxaparin thromboprophylaxis in gastric bypass patients: extended duration, dose stratification, and antifactor Xa activity.
    Borkgren-Okonek MJ; Hart RW; Pantano JE; Rantis PC; Guske PJ; Kane JM; Gordon N; Sambol NC
    Surg Obes Relat Dis; 2008; 4(5):625-31. PubMed ID: 18261965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation of childhood sexual abuse and other forms of maltreatment to 12-month postoperative outcomes in extremely obese gastric bypass patients.
    Grilo CM; White MA; Masheb RM; Rothschild BS; Burke-Martindale CH
    Obes Surg; 2006 Apr; 16(4):454-60. PubMed ID: 16608610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roux-en-Y gastric bypass decreases serum inflammatory markers and cardiovascular risk factors in obese diabetics.
    Rossi I; Omotosho P; Poirier J; Spagnoli A; Torquati A
    Surgery; 2021 Mar; 169(3):539-542. PubMed ID: 33168209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of venous thromboembolism prophylaxis in morbidly obese patients undergoing gastric bypass surgery.
    Cotter SA; Cantrell W; Fisher B; Shopnick R
    Obes Surg; 2005 Oct; 15(9):1316-20. PubMed ID: 16259895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.